ArticleIndian journal of ophthalmology2021
Use of offline artificial intelligence in a smartphone-based fundus camera for community screening of diabetic retinopathy.
Article in Indian journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.
- Diabetic Retinopathy Screening Approaches in Developing Countries: A Systematic Review and Meta-Analysis.Turkish journal of ophthalmology · 2025Pooled it
- Performance and limitation of machine learning algorithms for diabetic retinopathy screening and its application in health management: a meta-analysis.Biomedical engineering online · 2025Pooled it
- Use of Deep Neural Networks in the Detection and Automated Classification of Lesions Using Clinical Images in Ophthalmology, Dermatology, and Oral Medicine-A Systematic Review.Journal of digital imaging · 2023Pooled it
- Trial
- The diagnostic accuracy of AI-assisted diabetic retinopathy screening in primary care: a prospective validation study.Scandinavian journal of primary health care · 2026Article
- Accuracy of portable artificial intelligence-supported fundus camera in the screening of diabetic retinopathy in primary care.Archives of endocrinology and metabolism · 2026Article
- Clinical setting-dependent diagnostic accuracy of artificial intelligence and store-and-forward diabetic retinopathy screening: a systematic review and meta-analysis.NPJ digital medicine · 2026Article
- Real-world validation of an AI-based non-mydriatic fundus camera in the diagnosis of diabetic retinopathy in Liberia.Frontiers in digital health · 2026Article
- Systematic review and meta-analysis of regulator-approved deep learning systems for fundus diabetic retinopathy detections.NPJ digital medicine · 2025Article
- Artificial Intelligence-Based Uveitis Diagnosis Through Retinal Vasculature Analysis: A Paradigm Shift in Ocular Tuberculosis.Ophthalmology and therapy · 2025Article
- Empowering Portable Age-Related Macular Degeneration Screening: Evaluation of a Deep Learning Algorithm for a Smartphone Fundus Camera.BMJ open · 2024Article
- Clinical Applications and Future Directions of Smartphone Fundus Imaging.Diagnostics (Basel, Switzerland) · 2024Review
- Clinical utility of handheld fundus and smartphone-based camera for monitoring diabetic retinal diseases: a review study.International ophthalmology · 2024Review
- Artificial intelligence for diabetic retinopathy in low-income and middle-income countries: a scoping review.BMJ open diabetes research & care · 2023Article
- Clinical validation of a smartphone-based retinal camera for diabetic retinopathy screening.Acta diabetologica · 2023Article
- Examining the Role of Telemedicine in Diabetic Retinopathy.Journal of clinical medicine · 2023Review
- Asteroid Hyalosis: An Update on Prevalence, Risk Factors, Emerging Clinical Impact and Management Strategies.Clinical ophthalmology (Auckland, N.Z.) · 2023Review
- Diagnostic test accuracy of artificial intelligence in screening for referable diabetic retinopathy in real-world settings: A systematic review and meta-analysis.PLOS global public health · 2023Article
- Value of Combining Optical Coherence Tomography with Fundus Photography in Screening Retinopathy in Patients with High Myopia.Journal of healthcare engineering · 2022Article
- Commentary: Smartphone imaging integrated with offline artificial intelligence - A boon for the screening of diabetic retinopathy.Indian journal of ophthalmology · 2021Article
Corrections and comments
- Commented on by
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe aim of the study was to analyse the reliability of an offline artificial intelligence (AI) algorithm for community screening of diabetic retinopathy.
methodsA total of 1378 patients with diabetes visiting public dispensaries under the administration of the Municipal Corporation of Greater Mumbai between August 2018 and September 2019 were enrolled for the study. Fundus images were captured by non-specialist operators using a smartphone-based camera covering the posterior pole, including the disc and macula, and the nasal and temporal fields. The offline AI algorithm on the smartphone marked the images as referable diabetic retinopathy (RDR) or non-RDR, which were then compared against the grading by two vitreoretinal surgeons to derive upon the sensitivity and specificity of the algorithm.
resultsOut of 1378 patients, gradable fundus images were obtained and analysed for 1294 patients. The sensitivity and specificity of diagnosing RDR were 100% (95% CI: 94.72-100.00%) and 89.55% (95% CI: 87.76-91.16%), respectively; the same values for any diabetic retinopathy (DR) were 89.13% (95% CI: 82.71-93.79%) and 94.43% (95% CI: 91.89-94.74%), respectively, with no false-negative results.
conclusionThe robustness of the offline AI algorithm was established in this study making it a reliable tool for community-based DR screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.